Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-018785

Chief Executive Officer sold 8,252 shares at an average $0.70 ($5,803)

From the SEC's structured data for this filing

Trades in this filing

Brainard Diana · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-20 Sale : show line 1 in the form −3,097 $0.70 $2,153 819,224 D
2024-02-21 Sale : show line 2 in the form −5,155 $0.71 $3,650 814,069 D
Open-market sales · 8,252 sh · avg $0.70 · $5,803
Loading xslF345X05/ownership.xml…